Aug 21, 2018 7:30 am EDT Eyenovia to Present at the 20th Annual H.C. Wainwright Global Investment Conference
Aug 13, 2018 8:30 am EDT Eyenovia’s EYN PG21 Trial Evaluating High-Precision Microdose of Latanoprost Demonstrates Robust Intraocular Pressure Lowering and Patient Usability
Jul 31, 2018 8:30 am EDT Eyenovia Announces Conference Call and Webcast for Second Quarter 2018 Financial Results
Jul 9, 2018 7:30 am EDT Eyenovia Appoints Michael Rowe as Vice President of Marketing Ahead of Initiation of Multiple Phase III Programs
Jun 5, 2018 7:30 am EDT Eyenovia Receives Notices of Allowance from USPTO on Two Additional Patent Applications for Ophthalmic Drug Delivery
May 9, 2018 6:30 am EDT Eyenovia Reports First Quarter 2018 Financial Results and Completion of EYN PG21 Study
Apr 19, 2018 8:30 am EDT Eyenovia Announces Conference Call and Webcast for First Quarter 2018 Financial Results